Warp Sciences is a US startup applying AI and robotics to drug development through a next-generation preclinical CRO that makes and tests molecules for other drug developers rather than developing its own drugs. Founded by Kevin Weil, DJ Patil, Manohar Paluri and Solomon Reisberg, the company is building fully automated robotic labs in the US where chemists, AI-designed experiments and robotic execution generate proprietary data to train scientific AI models. It aims to reshore preclinical chemistry work that pharmaceutical companies have long outsourced to Chinese contract manufacturers such as WuXi AppTec.
1
Round
1
Industry
5
Tags
Oct 22, 2026
Latest raise
Funding activity · 1 round
Oct 22, 2026
$215M
Series A
Led by Lightspeed Venture Partners
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
